AQST Aquestive Therapeutics

• None no insider bought on the open market
• None no sales outside a trading plan
• $744K sold by 3 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Daniel Barber CEO
   Planned sale
   $106K 25,000 shares at $4.22 3.8% of stake
   Traded Oct 15 Filed Oct 16
   ↗
3. Daniel Barber CEO
   Planned sale
   $120K 25,000 shares at $4.82 3.7% of stake
   Traded Sep 15 Filed Sep 16
   ↗
4. Sherry Korczynski Chief Commercial Officer
   Planned sale
   $46K 8,750 shares at $5.22 3.6% of stake
   Traded Sep 9 Filed Sep 11
   ↗
5. Daniel Barber CEO
   Planned sale
   $107K 25,000 shares at $4.29 4.1% of stake
   Traded Aug 17 Filed Aug 18
   ↗
6. Daniel Barber CEO
   Planned sale
   $100K 25,000 shares at $4.01 3.9% of stake
   Traded Jul 15–16 Filed Jul 17
   ↗
7. Julie Krop Director
   Planned sale
   $125K 25,000 shares at $5.02 100% of stake
   Traded Jun 23 Filed Jun 24
   ↗
8. Daniel Barber CEO
   Planned sale
   $104K 25,000 shares at $4.16 3.8% of stake
   Traded Jun 15 Filed Jun 16
   ↗
9. Daniel Barber CEO
   Planned sale
   $35K 8,257 shares at $4.29 1.2% of stake
   Traded May 15 Filed May 18
   ↗
10. Cassie Jung COO
    Planned sale
    $474K 67,575 shares at $7.01 22% of stake
    Traded Oct 15, 2025 Filed Oct 17, 2025
    ↗
11. Carl N Kraus Chief Medical Officer
    Planned sale
    $142K 20,272 shares at $7.00 6.7% of stake
    Traded Oct 15, 2025 Filed Oct 17, 2025
    ↗
12. Peter E. Boyd See Remarks
    Planned sale
    $70K 10,000 shares at $7.00 3.6% of stake
    Traded Oct 15, 2025 Filed Oct 17, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 12 stock grants, 10 share withholdings for taxes, 7 sales to cover taxes, 5 option exercises, and 1 other transaction.